Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline

被引:34
作者
Asanad, Samuel [1 ,2 ]
Fantini, Michele [1 ,2 ,3 ]
Sultan, William [1 ]
Nassisi, Marco [1 ,4 ]
Felix, Christian M. [2 ]
Wu, Jessica [2 ]
Karanjia, Rustum [1 ,2 ,5 ,6 ]
Ross-Cisneros, Fred N. [1 ]
Sagare, Abhay P. [7 ]
Zlokovic, Berislav V. [7 ]
Chui, Helena C. [8 ]
Pogoda, Janice M. [9 ]
Arakaki, Xianghong [10 ]
Fonteh, Alfred N. [10 ]
Sadun, Alfredo A. A. A. [1 ,2 ]
Harrington, Michael G. [10 ]
机构
[1] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA
[3] Univ Udine, Dept Med, Ophthalmol, Udine, Italy
[4] Univ Milan, Dept Clin Sci & Community Hlth, IRCCS Ca Granda Fdn Osped Maggiore Policlin, Ophthalmol Unit, Milan, Italy
[5] Univ Ottawa, Dept Ophthalmol, Ottawa, ON, Canada
[6] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[7] Univ Southern Calif, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90007 USA
[8] Univ Southern Calif, Dept Neurol, Los Angeles, CA USA
[9] Cipher Biostat Reporting, Reno, NV USA
[10] Huntington Med Res Inst, Pasadena, CA USA
来源
PLOS ONE | 2020年 / 15卷 / 05期
关键词
OPTICAL COHERENCE TOMOGRAPHY; ALZHEIMERS-DISEASE; VISUAL IMPAIRMENT; ABNORMALITIES; BIOMARKERS; LIFE;
D O I
10.1371/journal.pone.0232785
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Alzheimer's disease (AD) pathology precedes symptoms and its detection can identify at risk individuals who may benefit from early treatment. Since the retinal nerve fiber layer (RNFL) is depleted in established AD, we tested whether its thickness can predict whether cognitively healthy (CH) individuals have a normal or pathological cerebrospinal fluid (CSF) A beta(42) (A) and tau (T) ratio. Methods As part of an ongoing longitudinal study, we enrolled CH individuals, excluding those with cognitive impairment and significant ocular pathology. We classified the CH group into two sub-groups, normal (CH-NAT, n = 16) or pathological (CH-PAT, n = 27), using a logistic regression model from the CSF AT ratio that identified >85% of patients with a clinically probable AD diagnosis. Spectral-domain optical coherence tomography (OCT) was acquired for RNFL, ganglion cell-inner plexiform layer (GC-IPL), and macular thickness. Group differences were tested using mixed model repeated measures and a classification model derived using multiple logistic regression. Results Mean age (standard deviation) in the CH-PAT group (n = 27; 75.2 8.4 years) was similar (p = 0.50) to the CH-NAT group (n = 16; 74.1 7.9 years). Mean RNFL (standard error) was thinner in the CH-PAT group by 9.8 (2.7) mu m; p < 0.001. RNFL thickness classified CH-NAT vs. CH-PAT with 87% sensitivity and 56.3% specificity. Conclusions Our retinal data predict which individuals have CSF biomarkers of AD pathology before cognitive deficits are detectable with 87% sensitivity. Such results from easy-to-acquire, objective and non-invasive measurements of the RNFL merit further study of OCT technology to monitor or screen for early AD pathology.
引用
收藏
页数:13
相关论文
共 67 条
  • [51] Color Discrimination Performance in Patients with Alzheimer's Disease
    Salamone, Giovanna
    Di Lorenzo, Concetta
    Mosti, Serena
    Lupo, Federica
    Cravello, Luca
    Palmer, Katie
    Musicco, Massimo
    Caltagirone, Carlo
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (06) : 501 - 507
  • [52] Santos Claudia Y, 2018, Alzheimers Dement (Amst), V10, P196, DOI 10.1016/j.dadm.2018.01.003
  • [53] Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
    Schoen, Christian
    Hoffmann, Nadine A.
    Ochs, Simon M.
    Burgold, Steffen
    Filser, Severin
    Steinbach, Sonja
    Seeliger, Mathias W.
    Arzberger, Thomas
    Goedert, Michel
    Kretzschmar, Hans A.
    Schmidt, Boris
    Herms, Jochen
    [J]. PLOS ONE, 2012, 7 (12):
  • [54] Retinal Nerve Fiber Layer Thickness is Associated with Episodic Memory Deficit in Mild Cognitive Impairment Patients
    Shen, Yuan
    Liu, Liang
    Cheng, Yan
    Feng, Wei
    Shi, Zhongyong
    Zhu, Yikang
    Wu, Wenyuan
    Li, Chunbo
    [J]. CURRENT ALZHEIMER RESEARCH, 2014, 11 (03) : 259 - 266
  • [55] The attenuation of retinal nerve fiber layer thickness and cognitive deterioration
    Shen, Yuan
    Shi, Zhongyong
    Jia, Renbao
    Zhu, Yikang
    Cheng, Yan
    Feng, Wei
    Li, Chunbo
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7
  • [56] Greater Attenuation of Retinal Nerve Fiber Layer Thickness in Alzheimer's Disease Patients
    Shi, Zhongyong
    Wu, Yujie
    Wang, Meijuan
    Cao, Jing
    Feng, Wei
    Cheng, Yan
    Li, Chunbo
    Shen, Yuan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 40 (02) : 277 - 283
  • [57] Prediction of Cognitive Decline by Positron Emission Tomography of Brain Amyloid and Tau
    Small, Gary W.
    Siddarth, Prabha
    Kepe, Vladimir
    Ercoli, Linda M.
    Burggren, Alison C.
    Bookheimer, Susan Y.
    Miller, Karen J.
    Kim, Jeanne
    Lavretsky, Helen
    Huang, S. -C.
    Barrio, Jorge R.
    [J]. ARCHIVES OF NEUROLOGY, 2012, 69 (02) : 215 - 222
  • [58] Psychometric Limitations of the Mini-Mental State Examination Among Nondemented Older Adults: An Evaluation of Neurocognitive and Magnetic Resonance Imaging Correlates
    Spencer, Robert J.
    Wendell, Carrington R.
    Giggey, Paul P.
    Katzel, Leslie I.
    Lefkowitz, David M.
    Siegel, Eliot L.
    Waldstein, Shari R.
    [J]. EXPERIMENTAL AGING RESEARCH, 2013, 39 (04) : 382 - 397
  • [59] OPINION Preclinical Alzheimer disease-the challenges ahead
    Sperling, Reisa A.
    Karlawish, Jason
    Johnson, Keith A.
    [J]. NATURE REVIEWS NEUROLOGY, 2013, 9 (01) : 54 - 58
  • [60] Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
    Tapiola, Tero
    Alafuzoff, Irina
    Herukka, Sanna-Kaisa
    Parkkinen, Laura
    Hartikainen, Paivi
    Soininen, Hilkka
    Pirttila, Tuula
    [J]. ARCHIVES OF NEUROLOGY, 2009, 66 (03) : 382 - 389